Immunocore Holdings plc (IMCR) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
IMCR currently has 50.8M outstanding shares. with minimal authorized share overhang for future dilution. The company has minimally diluted shareholders by 1.54% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 06, 2026 |
10-Q filing | 50.8M shares outstanding |
51M | 0 |
| Nov 06, 2025 |
10-Q filing | 50.4M shares outstanding |
50M | 0 |
| Aug 07, 2025 |
10-Q filing | 50.3M shares outstanding |
50M | 0 |
| May 07, 2025 |
10-Q filing | 50.1M shares outstanding |
50M | 0 |
| Feb 26, 2025 |
10-K filing | 50.0M shares outstanding |
50M | 0 |
| Nov 06, 2024 |
10-Q filing | 50.0M shares outstanding |
50M | 0 |
| Aug 08, 2024 |
10-Q filing | 50.0M shares outstanding |
50M | 0 |
| May 08, 2024 |
10-Q filing | 49.9M shares outstanding |
50M | 0 |
| Apr 05, 2024 |
8-K filing: Immunocore Holdings plc filed a prospectus supplement regarding the resale of up to 1,220,063 American Depositary Shares by a selling shareholder. |
49M | 0 |
| Feb 28, 2024 |
10-K filing | 48.9M shares outstanding |
49M | 0 |
| Mar 01, 2023 |
20-F filing | 48.1M shares outstanding |
48M | 0 |
| Mar 03, 2022 |
20-F filing | 43.9M shares outstanding |
44M | 0 |
| Mar 25, 2021 |
20-F filing | 31.8M shares outstanding |
32M | 0 |
| Jan 15, 2021 |
F-1 filing: This F-1 filing discusses the company's financial performance for the nine months ended September 30, 2020 and 2019, and describes a proposed offering of ADSs representing ordinary shares, with an option for underwriters to purchase additional ADSs. |
5.5M | 0 |